Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Direct Mouse Genotyping Kit: PCR Workflow
2026-09-28
The Direct Mouse Genotyping Kit K1025 supports rapid genomic DNA release and PCR amplification directly from mouse tissue lysates, avoiding conventional DNA purification for routine allele screening. It is appropriate for validated PCR genotyping and high-throughput colony work, but applications requiring purified or high-molecular-weight DNA require separate sample preparation and validation.
-
L. gasseri ATCC33323 Protects in DSS Colitis
2026-09-28
In a mouse model of DSS-induced colitis, Lactobacillus gasseri ATCC33323 improved disease-associated inflammation and intestinal barrier features. The study links this protection to E-cadherin and NR1I3, while its genetic perturbation experiments strengthen the evidence that E-cadherin contributes to the probiotic’s effects.
-
SB 202190 in Gastric Cancer Assembloid Research
2026-09-27
Use SB 202190 to test how p38α/β activity shapes tumor–stroma signaling and drug response in patient-derived gastric cancer assembloids. A staged dose-and-time workflow separates pathway effects from toxicity, while practical controls help interpret changes in viability, inflammation, and apoptosis.
-
DRB as a Causal Probe of RNA and Cell Fate
2026-09-26
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) can help distinguish transcription-dependent effects from RNA-level regulation. This article connects its kinase pharmacology to YTHDF1-driven stem-cell fate research and outlines assay choices that keep those mechanisms distinct.
-
Resiquimod (R-848): From TLR Biology to Tumor Ablation
2026-09-25
Explore how Resiquimod (R-848) can connect innate immune signaling with local tumor ablation. We examine a thermal-protective, dual-responsive hydrogel study, its translational implications, and practical considerations for designing reproducible TLR7/8 experiments.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-09-25
A study in rat dental follicle cells reports that puerarin enhanced osteogenic differentiation alongside increased nitric oxide, cGMP, and osteogenic-marker expression. Inhibition with L-NMMA weakened several of these effects, supporting a contribution from nitric oxide signaling while leaving the pathway’s precise causal steps and clinical relevance unresolved.
-
Staurosporine Workflows for TNBC Signaling Research
2026-09-24
Use Staurosporine as a carefully titrated pathway-perturbation and apoptosis control when studying TNBC motility—not as a selective test of the TBXA2R–ERM axis. This workflow pairs short, low-dose signaling experiments with viability-matched migration assays to help separate kinase-dependent effects from cell death.
-
Protein A/G Magnetic Co-IP/IP Kit for Babesia
2026-09-24
Connect AP2-M’s reported effects on Babesia development to a practical follow-up workflow for capturing candidate protein partners. The Protein A/G Magnetic Co-IP/IP Kit supports antibody-directed IP and co-IP, with magnetic handling suited to scarce or degradation-sensitive samples.
-
BML-277 for Chk2 and DNA Damage Assays
2026-09-23
This scenario-driven guide explains how to use BML-277 (SKU B1236) when interpreting Chk2-dependent cell viability, radiation-response, and DNA damage experiments. It separates biochemical potency from cellular response, outlines practical handling and control strategies, and describes the limits of connecting Chk2 inhibition to emerging cGAS research.
-
VX-765 Workflows for Caspase-1 Research
2026-09-23
VX-765 enables selective interrogation of caspase-1-driven cytokine release, pyroptosis, and barrier inflammation without treating every inflammatory readout as equivalent. This practical guide connects cell-based assays, biochemical confirmation, BBB models, rheumatoid arthritis research, and infectious-disease applications with troubleshooting strategies for reproducible results.
-
L-Threonine for Metabolic and ALP Assays
2026-09-22
L-Threonine provides a controllable nutrient input for cell culture optimization, metabolic profiling, and nutritional intervention studies. This guide also shows how to keep L-Threonine biology separate from metal-free carbon-dot alkaline phosphatase assays so nutrient perturbations do not become analytical confounders.
-
Ciclesonide Workflows for Respiratory Research
2026-09-22
Build reproducible airway studies around Ciclesonide’s measurable conversion to desisobutyryl-ciclesonide, from epithelial-cell activation assays to inflammation-focused animal models. The workflow also explains how recent ERAD-hijacking research informs assay design without incorrectly treating a glucocorticoid prodrug as a validated protein degrader.
-
CRTC–CREB Senses Proteotoxic Stress in Drosophila
2026-09-21
The reference study identifies CRTC–CREB as an adaptive transcriptional sensor activated by proteasome inhibition through ROS and JNK signaling. Using Drosophila stress, Huntington’s disease, and aging models alongside 293T-cell experiments, the authors show that increasing this pathway improves proteostasis and reduces protein aggregation.
-
Neurotensin: From NTR1 Signaling to Translation
2026-09-21
Neurotensin is more than a receptor agonist: it is a strategic probe for connecting NTR1 activation with receptor recycling, AFTPH-dependent trafficking, and miR-133α modulation in gastrointestinal models. This thought-leadership guide shows how translational teams can turn a Neurotensin receptor 1 activator into a controlled, causally informative workflow while avoiding overinterpretation across assay domains.
-
Viral RIPK3 Degradation and Inflammation
2026-09-20
Liu and colleagues identified a cowpox virus protein that recruits host SCF ubiquitin-ligase machinery to promote proteasomal degradation of RIPK3, thereby suppressing necroptosis while enhancing viral fitness and inflammatory disease. The study connects pathogen–host evolution with a defined protein-degradation mechanism and provides a framework for testing how ubiquitin and neddylation systems shape antiviral cell death.